Article    Table of Contents                    Full Text of this article Free    Figures/Tables List  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    Gourevitch, M. N.    Friedland, G. H.    Related Articles in PubMed    PubMed Citation    PubMed

ARTICLE

Effects of HIV Infection on the Serologic Manifestations and Response to Treatment of Syphilis in Intravenous Drug Users

Marc N. Gourevitch; Peter A. Selwyn; Katherine Davenny; Donna Buono; Ellie E. Schoenbaum; Robert S. Klein; and Gerald H. Friedland

1 March 1993 | Volume 118 Issue 5 | Pages 350-355

Objective: To describe the effects of human immunodeficiency virus (HIV) infection on the serologic manifestations and response to treatment of syphilis in intravenous drug users.

Design: Cohort study of intravenous drug users.

Setting: Medical clinic in a hospital-based methadone maintenance treatment program in New York City.

Patients: Fifty patients with syphilis, of whom 31 were HIV seropositive and 19 HIV seronegative.

Measurements: Serologic tests for syphilis and clinical manifestations.

Results: Stage of syphilis at presentation was not associated with HIV serologic status. No unusual or fulminant manifestations of early syphilis or neuro-syphilis were noted among HIV-seropositive cases. Maximum nontreponemal titers were higher among HIV-seropositive (median, 1:128) than among HIV-seronegative (median, 1:32) patients with syphilis (P = 0.05); this difference was present only among patients with first-episode syphilis. All 26 evaluable, HIV-seropositive patients treated for syphilis responded appropriately, including 13 patients given standard or less-than-standard doses of penicillin. Seven of 43 patients (16%) showed reversion to negative treponemal antibody assay results after treatment for syphilis; this finding was not associated with HIV infection, CD4 count, or stage of syphilis. Low nontreponemal titer was weakly associated with treponemal test reversion.

Conclusions: Infection with HIV did not alter the stage at presentation, clinical course, serologic manifestations, or response to treatment of syphilis in this cohort of intravenous drug users.

Author and Article Information

From Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York.
Requests for Reprints: Marc N. Gourevitch, MD, Department of Epidemiology and Social Medicine, Montefiore Medical Center, 111 East 210th Street, Bronx, NY 10467.
Acknowledgments: The authors thank Phil Alcabes, PhD, and Zena Stein, MA, MB, Bch, for comments on the manuscript; Sarah McLaughlin for technical assistance; and Nancy Budner, MPH, Andrea Gachupin-Garcia, and Jane Shaw, MD, for assistance with data collection.
Grant Support: By Centers for Disease Control Cooperative Agreement #U64/CCU200714 and by grants from the National Institute of Drug Abuse (#RO1 DA04347-05) and the Aaron Diamond Foundation.

This article has been cited by other articles:

				K G Ghanem, E J Erbelding, Z S Wiener, and A M Rompalo Serological response to syphilis treatment in HIV-positive and HIV-negative patients attending sexually transmitted diseases clinics Sex. Transm. Inf., April 1, 2007; 83(2): 97 - 101. [Abstract] [Full Text] [PDF]

				G T Smith, D Goldmeier, and C Migdal Neurosyphilis with optic neuritis: an update Postgrad. Med. J., January 1, 2006; 82(963): 36 - 39. [Full Text] [PDF]

				R. E. Baughn and D. M. Musher Secondary Syphilitic Lesions Clin. Microbiol. Rev., January 1, 2005; 18(1): 205 - 216. [Abstract] [Full Text] [PDF]

				HIV and Syphilis Coinfection: Trends and Interactions AIDS Clinical Care, February 1, 2003; 2003(201): 1 - 1. [Full Text]

				V. G. Fowler Jr, G. L. Maxwell, S. A. Myers, C. R. Shea, C. N. Livengood III, V. G. Prieto, and C. B. Hicks Failure of Benzathine Penicillin in a Case of Seronegative Secondary Syphilis in a Patient With Acquired Immunodeficiency Syndrome: Case Report and Review of the Literature Arch Dermatol, October 1, 2001; 137(10): 1374 - 1376. [Full Text] [PDF]

				M. Genc and W. J Ledger Syphilis in pregnancy Sex. Transm. Inf., April 1, 2000; 76(2): 73 - 79. [Abstract] [Full Text] [PDF]

				A. E. Singh and B. Romanowski Syphilis: Review with Emphasis on Clinical, Epidemiologic, and Some Biologic Features Clin. Microbiol. Rev., April 1, 1999; 12(2): 187 - 209. [Abstract] [Full Text] [PDF]

				R. T. Rolfs, M. R. Joesoef, E. F. Hendershot, A. M. Rompalo, M. H. Augenbraun, M. Chiu, G. Bolan, S. C. Johnson, P. French, E. Steen, et al. A Randomized Trial of Enhanced Therapy for Early Syphilis in Patients with and without Human Immunodeficiency Virus Infection N. Engl. J. Med., July 31, 1997; 337(5): 307 - 314. [Abstract] [Full Text] [PDF]

				E. C. Tramont, J. Rodriguez-Bano, G. Izquierdo, M.A. Muniain, M. N. Gourevitch, R. S. Klein, E. E. Schoenbaum, S. M. Gordon, M. E. Eaton, S. A. Lukehart, et al. Neurosyphilis in Patients with Human Immunodeficiency Virus Infection N. Engl. J. Med., April 27, 1995; 332(17): 1169 - 1171. [Full Text]

				P. G. O'Connor, P. A. Selwyn, and R. S. Schottenfeld Medical Care for Injection-Drug Users with Human Immunodeficiency Virus Infection N. Engl. J. Med., August 18, 1994; 331(7): 450 - 459. [Full Text]

				Syphilis and HIV Disease: Symptoms, Signs, Serology, and Treatment Response Journal Watch Dermatology, April 1, 1993; 1993(401): 6 - 6. [Full Text]